Opko Inks $16.5M Investor Deal After SEC Suit Drops Stock

Law360 (June 29, 2020, 9:33 PM EDT) -- Opko Health Inc. has reached a $16.5 million deal resolving investor claims that it artificially inflated the stock of companies it had invested in, causing its own stock to drop when the U.S. Securities and Exchange Commission sued over the behavior, according to settlement papers filed in Florida federal court Monday.

Lead plaintiff The Amitim Funds told the court it has agreed to resolve all claims in the case in exchange for a cash payment of $16.5 million for the benefit of the settlement class, saying the deal secures the "greatest possible monetary recovery" for the class while taking into account...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!